RF Acquisition Corp II Ordinary Shares (RFAI)

This article identifies several stocks showing significant premarket activity on Monday, August 24, 2026. It highlights top gainers including Sadot Group Inc. (SDOT) and Picard Medical, Inc. (PMI), and top losers such as RF Acquisition Corp II (RFAI) and REGENXBIO Inc. (RGNX), offering traders an early look at potential market movements.

Shareholders of RF Acquisition Corp II (RFAI) have approved all proposals for its business combination with NYB Holdings Limited and Nanyang Biologics. The merger will make Nanyang Biologics a wholly-owned subsidiary of NYB Holdings' PubCo vehicle. Despite a strong quorum, nearly 3.96 million shares were submitted for redemption, leaving the final cash balance and public float uncertain until the deal closes.

RF Acquisition Corp II (RFAI) shareholders approved all proposals related to its business combination with NYB Holdings Limited and Nanyang Biologics Pte. Ltd. at an extraordinary general meeting on August 19, 2026. This includes the merger agreement, Nasdaq share issuance, and an equity incentive plan, all passing with significant majorities. Despite the approvals, preliminary redemption requests for nearly 4 million ordinary shares have been submitted, and the completion of the business combination remains subject to closing conditions.

RF Acquisition Corp II shares surged 473.45% in after-hours trading after shareholders approved a merger with Singapore-based AI drug discovery firm Nanyang Biologics Pte. Ltd. The combined entity will operate as NYB Holdings Limited, and the approval clears the path for the company to become a publicly traded AI biotech platform. Preliminary redemption requests for 3,956,323 ordinary shares were noted, which could impact the final share structure.

Shares of RF Acquisition Corp II (NASDAQ: RFAI) surged by over 260% in premarket trading on Friday after shareholders approved a business combination with Nanyang Biologics Pte. Ltd. This merger, overwhelmingly supported by votes, will lead to the combined entity operating under NYB Holdings Limited and is expected to clear the path for a Nasdaq listing. The approval of related proposals and preliminary redemption requests were also disclosed, with final figures to be announced upon deal completion.